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ABSTRACT 
Infection or inflammation in the reproductive tract either via pathogenic intrusion or systemic diseases, reportedly are closely associated 
with deterioration  in male  fertility parameters.  There are  various proposed mechanisms  to explain how  reproductive  tract  infection or 
inflammation may  curb male  fecundity. One of  the prominent mechanisms  is  via  the over‐production of  reactive oxygen  species  (ROS) 
inducing  testicular  oxidative  stress  (OS).  In  normal  conditions,  testicular  cells  produce  ROS  at modest  levels  to maintain  physiological 
functions. However,  in  inflammatory  state,  the  surge  of  pro‐inflammatory mediators,  cytokines  lead  to  infiltration  of  immune  cells  (as 
observed by increased seminal leukocytes number) and these leukocytes serve as major contributors in the increased seminal plasma ROS 
levels  that  overwhelm  the  testicular  antioxidant  capacities.  This  initiates  oxidative  damage  to  the  testicular  cells  to  impair  sperm 
production,  as  well  as  sperm  membrane  damage,  disruption  of  essential  signalling  cascades,  sperm  mitochondrial  and  nuclear  DNA 
damage  and  thereby  impairing  overall  sperm  functions.  There  are  number  of  studies  reporting  diversified  hypothesis  of 
infection/inflammation‐induced male reproductive problems. This article aims to review the available  information and present a precise 
overview of possible mechanisms relating male reproductive tract inflammation and male infertility.  
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INTRODUCTION	
A couple may be considered infertile when they fail to 
conceive even after regular unprotected sexual intercourse for a 
period of one year.1 Almost 15% couples are infertile among all 
sexually active ones.2 In isolation, or combination with a female 
element, the male factor represents about 50% of the infertility 
cases.1, 3 
There can be varied causes for infertility.4-9 The reproductive 
system of both sexes can be compromised by infectious agents. 
It is estimated that approximately 15% of male infertility is 
caused by male genital urinary tract infections,10 affecting 
different sites of male reproductive system, such as testis, 
epididymis, and male accessory glands.11 
Spermatogenesis itself may be impaired at different levels of 
sperm production, maturation and transport by urogenital 
infections, which can either be sexually transmitted or non-
sexually transmitted.11 Chlamydia trachomatis and Neisseria 
gonorrhea are of the most common sexually transmitted 
microorganisms that interferes with male fertility.12 Male 
infertility is less frequently caused by epididymo-orchitis which 
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is primarily transmitted in nonsexual ways by Escherichia coli. 
Lower genital tract infections tend to have low importance. 
These and other male-genital urinary-tract infections can, 
however, contribute to a microbial infiltration and colonization 
in seminal plasma.12-14 
Different mechanisms are proposed to explain how infection 
or inflammation in the reproductive system can reduce male 
fertility.14-16 One of the prominent mechanisms involve 
induction of testicular oxidative stress (OS) through 
overproduction of reactive oxygen species (ROS).17-19 Testicular 
cells produce ROS to maintain their physiological function at 
modest levels, in normal conditions.17,20 In inflammatory state, 
however, cytokines and inflammatory mediators lead to immune 
cell infiltration (evidenced by increase in the number of seminal 
leucocytes)14 and these leukocytes serve as major 
contributors21,22 in the increased seminal plasma ROS levels that 
overwhelms the testicular antioxidant capacities. This initiates 
oxidative damage to the testicular cells to impair sperm 
production, as well as sperm membrane damage, disruption of 
essential signalling cascades, sperm mitochondrial and nuclear 
DNA damage and thereby impairing overall sperm 
functions.13,17, 23  
There are several studies which report diversified hypotheses 
of male reproductive problems caused by 
infection/inflammation.12,21 This article aims to review the 
information available and present an accurate overview of the 
possible mechanisms for male reproductive tract infection-
induced male infertility. 
REPRODUCTIVE	TRACT	INFECTIONS	AND	MALE	
INFERTILITY 
Lack of conception in a period of one year with repeated 
unprotected coitus among couples is defined as infertility. 
Generally, the cause for underlying infertility may be due to 
non-physiological to pathological conditions prevailing in either 
male or female and many a time among both. In male partner 
few causes that may lead to infertility include, endocrine 
hormonal disorders, metabolic causes, genital infection that lead 
to semen infections, obstruction in genital tract and many more.  
Variety of micro-organisms may lead to infertility among 
male population. Microorganisms generally colonize in the 
semen irrespective of their origin of infection either in the main 
genital tract or genitourinary tract of the male. Bacterial agents 
such as genital mycoplasmas generally invade the genital tracts 
such as ureaplasma urealyticum and mycoplasma hominis.24 
Urethritis, prostatitis and few instances orchitis are caused due 
to Ureaplasma urealyticum or may be Mycoplasma hominis. It 
is further confirmed that ureaplasmas are causing non-
chlamydial, non-gonococcal urethritis in males.25 But many 
studies revealed that M. hominis and U. urealyticum have not 
caused the decline in the quality of sperm but incubation with 
M. hominis has resulted in adverse effect on sperm motility, 
morphology and fertilizing potential. Elevated concentrations of 
granulocyte elastase in the seminal plasma are the confirmatory 
factors those are the indicators of male genital tract infections 
and around 20-30% infertile men have silent genital 
inflammations according to the WHO.26,27 Changes in sperm 
characteristics and apoptotic markers, semen contamination by 
excess leucocytes as an outcome of inflammation in the male 
genial tract in addition toxic reactive oxygen species (ROS) 
depending on the infectious agents were implicated as the 




Two mycoplasma species are clinically relevant. These are 
M. genitalium and M. hominis.24,28 Mycoplasma infections are 
prevalent at 4.8 percent for M. genitalium, and 9.6 percent for 
M. hominis.29 Of the men with persistent urethritis, 41 percent 
are positive for M. genitalium.30 These infections reduce sperm 
motility and morphology and can induce sperm DNA 
damage.24,31 Gallegos et al. (2008) reported that high ROS 
production induced by inflammation is causative of DNA 
damage in mycoplasma- infections. Sperm DNA damage 
reduced significantly following a course of antibiotics and anti-
inflammatory steroids (p < 0.001).32 
Ureaplasma 
Ureaplasma urealyticum and Ureaplasma parvum are the 
two clinically significant ureaplasma species which are 
accountable for male infertility with an incidence of 15.6% and 
2.9% respectively.29 Infection rates for ureaplasma in patients 
with male infertility range between 5% and 42%.33 While sperm 
motility and normal sperm morphology reduce, damage to 
sperm DNA elevates. Because ureaplasma does not cause an 
inflammatory process that would degrade the quality of 
semen,34 it remains unknown why these semen parameters 
deteriorate.24,34 These pathogens accrue in the urethra and are 
likely to bind directly to sperm following ejaculation,34 a 
process that is believed to cause increased damage to DNA and 
loss of membrane integrity through ROS formation.32 
Escherichia coli 
Escherichia coli is the most important bacterium in male 
infertility caused by infection.35 E. coli reduces sperm motility, 
decreases vitality, and increases damage to DNA.36,37 E. coli-
mediated infertility has many modalities of how male infertility 
may be caused. For example, E. coli induces leukocyte 
recruitment and thus encourages neutrophilic ROS 
development.38 Proinflammatory cytokines, such as IL‐6, can 
break cell membranes directly, decreasing sperm motility.39 
Similarly, the E. coli reduces sperm membrane integrity by 
directly binding to their membrane and adding porins to the 
membrane of the spermatozoa.40 Porin formation, in effect, 
induces cytoplasmic material to be released and contributes to a 
significant reduction in viability from 80% to 100%. Finally, the 
attached haemolytic subspecies E. coli decreases sperm vitality 
by decreasing the sperm plasma membrane potential that 
mediates the production of intracellular ROS.41 
Viral infections 
Human Immunodeficiency Virus 
Human immunodeficiency virus (HIV) reduces 
sperm motility, vitality and forward progression once the counts 
of CD4 cells are less than 350 cells / microliter.42 Otherwise, 
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asymptomatic HIV-seropositive people do not display reduced 
fertility.42 Recruitment of monocytes, macrophages, and 
leucocytes in semen is observed in people with symptomatic 
HIV infections.42 With existing extremely active antiretroviral 
therapy (HAART) regimens improving HIV-infected men's life 
expectancy, research on how HAART affects male fertility 
reveal a detrimental effect on semen quality.43 Use of non-
nucleoside reverse transcriptase inhibitors can induce oxidative 
stress because these are mitochondrially toxic44,45 and damage 
the mitochondrial membrane potential.46 
Hepatitis 
Both hepatitis B and hepatitis C are viruses which have been 
shown to cause male infertility. Hepatitis B is known to 
aggravate parameters of fertility due to its ability to move 
through the blood–test barrier.42,47 Given the ability of the 
hepatitis B virus to move through the blood–testis barrier, it can 
transmit its genome directly into spermatozoa leading to 
defective spermiogenesis and lower fertilization levels.48 
Hepatitis B-exposed spermatozoa were identified with increased 
externalization of phosphatidylserine and assessed lipid 
peroxidation by MDA formation.49,50 High seminal 
concentrations of IL‐18 were found in men with chronic 
hepatitis B, which causes natural killer cells to secrete 
proinflammatory cytokine INF‐ɣ.50 These authors found a 
positive association between the formation of inner MDA and 
the concentration of IL‐18, indicating the formation of MDA is 
caused by an inflammatory process. There is currently no 
research relating directly to IL‐18 and leucocyte activation in 
the male reproductive tract from hepatitis B infection, however. 
Transmission of hepatitis C comes primarily from intravenous 
drug abuse and mother-to-child transmission.51,52 Concerning 
the ongoing opiate crisis in the United States, primary opiate 
abusers are reproductive-age (mean age of 22.9 years) and 
contribute significantly to increased hepatitis C transmission.51 
The hepatitis C virus, unlike hepatitis B, does not pass through 
the blood–testis barrier and cannot cause direct oxidative stress 
to spermatozoa.42 Infections with chronic hepatitis C induce 
systemic elevations of TNF‐α and NO.53 As a result, chronic 
inflammation and lymphocyte activation and 
polymorphonuclear leucocyte activation appear.54 
Polymorphonuclear leucocytes generate ROS via NOX2, 
resulting in a loss of the mitochondrial membrane potential in 
the spermatozoa resulting in further propagation of ROS and 
OS.53,54 Hepatitis C‐induced OS leads sperm motility to 
decrease, but unaffected ejaculatory volume, apoptosis and 
enhanced DNA damage.53, 54 
Sexually transmitted diseases and male infertility 
Sexually transmitted diseases (STD) disrupt either the 
hormonal axis, spermatogenesis or transport of sperm in the 
tract. STDs contribute its major share in the male infertility; 
high titer of seropositive chlamydia antibodies which is a 
marker of severe infections has contributed for the male 
infertility.55 Polymerase chain reaction (PCR) which detects 
chlamydia, Mycoplasma hominis, and Ureaplasma urealyticum 
in semen samples of infertile men was significantly higher 
compared to the fertile men indicating a strong association of 
STD infection in the infertility.56 Lipopolysaccharides extracted 
from chlamydia have caused a total mortality of spermatozoa in 
the incubation studies and also a decline in sperm motility.40 
Genital mycoplasma and ureaplasma were proved to be 
causative agents in male infertility causing declined sperm 
motility and membrane alterations in addition to DNA 
damage.34 Neisseria gonorrhoeae DNA was detected in infertile 
men semen samples and trichomonas vaginalis has caused a 
lower sperm motility.57 In addition, Epstein barr virus, 
cytomegalovirus, herpes, papilloma virus, hepatitis and human 
deficiency virus have their chances in causing infertility in men 
but the association of unknown origin due to STDs has not been 
extensively studied to arrive at a strong correlation with 
individualized STD infection and male infertility. 
Neisseria gonorrhoeae 
The male urogenital tract represents two types of changes 
after infection - a rise in diameter and a decrease in seminal 
flow velocity.58 This will result in elevated ROS levels. The 
gonorrhoea causative agent, N. gonorrhoeae, can colonize 
genital, rectal and nasopharyngeal mucosa during infection.59 
Gram-negative bacteria include, N. Gonorrhoeae are unusual in 
that they produce large quantities of peptidoglycan during 
development.60 N. gonorrhoeae is capable of activating TLR2, 
TLR4 and cytosolic receptor nucleotide-binding 
oligomerization (NOD)‐1 and NOD2 in the inborn immune 
response to the bacterial antigen. This cycle further stimulates 
the NF‐kB transcription factor and the adaptor-receptor-
interacting serine–threonine kinase 2 polyubiquitination 
(RIPK2)60. Activation of the NOD receptor suggests that the 
immune response can trigger not only cytokines (IL‐16) and 
chemokines, but it also induces complement proteins, growth 
factors (CSF1), and other cytosolic pattern recognition receptors 
on cell surfaces such as toll like receptors.60 In addition, IL‐1 
induces apoptosis in semen through the proliferation and 
differentiation of B- cells to trigger generations of neutrophils 
and monocytes with the help of chemoattractors such as IL‐8.58 
In N. gonorrhoeae-infection, expression of IL‐1 and IL‐8 have a 
significant clinical effect.61 Duru, Morshedi, and Oehninger 
(2000) have shown a negative correlation between seminal 
oxidative stress and concentration, function, and motility of the 
sperm. Cytokines and adipokines may also be proposed to be 
the mediator of semen quality and male infertility.58,62-66 A 
research further suggests that increased levels of IL‐1β were 
correlated with a reduction in sperm motility and a rise in 
seminal ROS and malondialdehyde (MDA), a lipid peroxidation 
by-product.67 
Chlamydia trachomatis 
Chlamydia trachomatis has the greatest prevalence rate 
worldwide with 4.2% for women and 2.7% for men who are 
infected68. Chlamydia provides people with a clinical problem 
as 50% of men diagnosed with chlamydia are not being treated 
empirically.69 The mechanism underneath male infertility 
induced by Chlamydia trachomatis remains unresolved. There 
are currently three main hypotheses: (a) high WBC levels as 
triggered by cytokines; (b) CD 14 receptor interaction; and (c) 
antisperm antibodies development.11 More precisely, this theory 
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suggests that infection frequently results in tissue damage when 
Chlamydia trachomatis enters the epithelial cell and thus 
activates IL‐1. IL‐1 (which consists of α and β subunits) 
activates polymorphonuclear WBCs and macrophages and 
induces IL‐6, IL‐8, IL‐10, TNF‐α, and IFN‐α subsequently. In 
infertile men, level IL‐6 in seminal plasma is higher.67 In the 
semen of infertile people, MDA rates were also higher, 
indicating that IL‐6 is involved in lipid peroxidation.70 This 
sequence of cascade responses, which leads to male infertility, 
implicitly triggers OS. The second mechanism proposed is to 
induce excessive ROS through the interaction between CD14 
receptor and high concentration of LPO present on the sperm 
membrane17, while the third mechanism proposed indicates the 
production of antisperm antibodies from the invasion of 
macrophages, lymphocytes, plasma cells and eosinophils. The 
activation cascade of ILs evokes further secretory antibodies to 
IgA, IgM, and IgG, where IgA and IgG are typically linked to 
lower rates of semen parameters and pregnancy outcomes.71,72 A 
meta-analysis of progression and outcome cytokine-level 
variations suggests that IL‐1, IL‐6, IL‐8, IL‐10, TNF‐α and 
IFN‐γ variations in hosts may potentially affect the patient's 
clinical outcome.61 Early diagnostic testing and antibiotic 
administration (i.e., macrolides) are essential for eradication of 
STD, given that there are several theories. 
Prostatitis 
Prostatitis remains the most extensively studied inflammatory 
diseases amongst male urogenital diseases. In case of acute and 
chronic bacterial prostatitis, pathogens can influence sperm 
either directly (based on the pathogen's strain) or indirectly 
through the activation of cytokines such as IL‐6, IL‐8 or 
TNF‐α73 in the seminal tract. Elevated levels of cytokine 
contribute to OS, which not only affects the spermatozoa14, but 
it can also potentially cause a systemic response by reducing 
testosterone hormone levels.15,74 Increased IL‐6, IL‐8, and 
TNF‐α levels may also impact sperm transit during ejaculation 
when the infection spreads to the testis.37,75 Enhanced oxidative 
stress often directly affects sperm DNA and thus affects the 
paternal genomic contribution to the embryo.76 Prostate 
infection and inflammation activate leucocytes which can 
increase ROS. For this reason, infections require immediate 
 
Figure 1. Various microbial pathologies of male reproductive tract. 
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treatment because a high amount of ROS may affect up to 35 
percent of men seeking infertility therapy. This is primarily 
because untreated prostatitis can cause oligozoospermia, 
azoospermia or asthenozoospermia.77 Untreated/undertreated 
infections may also cause chronic illness, which is harder to 
treat than acute illness. Four specific antibiotics - 
fluoroquinolones, tetracyclines, macrolides, and trimethoprim 
(alone or in combination with sulfamethoxazole) - were 
introduced as a treatment option in the case of bacterial 
prostatitis.78 Antibiotic administration remains the foundation 
for the treatment of bacterial prostatitis, and numerous studies 
have shown that antibiotics can improve semen parameters and 
pregnancy rates considerably. Nevertheless, antibiotic treatment 
needs to be done carefully and after proper drug resistance 
testing, because recent attention has also been paid to multidrug 
resistance.79 Combination treatment for patients is generally 
recommended if the first-line treatment is ineffective.80 While 
most combinations are indifferent or additive, ciprofloxacin and 
rifampin appear to be effective against Staphylococcus aureus,81 
while fluoroquinolones chelate with cations such as aluminium, 
magnesium, calcium, iron and zinc. This drug interaction 
significantly reduces the concentrations of serum drugs 
available for penetration into target tissues.81 Prostate epithelial 
cells can produce cell zinc which is multiple times higher than 
most other mammalian cells.82 The accumulation of zinc in the 
prostate may prevent fluoroquinolones from achieving their 
optimal efficacy, despite the above description. 
MALE	REPRODUCTIVE	TRACT	INFECTIONS	AND	
LEUKOCYTES		
Impairment of sperm functions can be triggered either by 
exposure to oxidants or by the reduced availability of protective 
antioxidant mechanisms in reproductive organs or by 
pathophysiological value of semen in male fertility factor.17, 83 
The main sources of these types of reactive oxygen (ROS) 
include immature sperm with excess residual cytoplasm and 
high seminal leukocytes,17,84 which normally appear in semen, 
even in that of healthy fertile men without a genital tract 
infection.85 While leukocytes are an essential component of the 
immune system, increasing numbers may not be a good sign in 
certain respects, or leukocyte can be considered unusual in 
certain parts of the body, and therefore special monitoring is 
needed. If a significant number of leukocytes in a semen sample 
are found, this is a problem as it may suggest an infection of the 
reproductive tract. If not treated, the testis and production of 
sperm may be further impaired. 
Despite their critical role in the body, the leukocytes produce 
large amount ROS, which represents 1000 times higher 
production of ROS,86 in view of immune surveillance and 
phagocytosis, including defective sperm.86,87 But the number of 
seminal leukocytes is higher for approximately 20-30% of 
infertile males. It results in considerably higher ROS production 
in conjunction with genital infection, inflammatory reactions 
and cellular defense mechanisms.12,14 The range of leucocyte 
types depends on the individual and mode of infection. While 
the largest type of leukocyte in semen is polymorphonuclear 
(PMN) granulocytes with 50 to 60%, macrophages and 
lymphocytes have 20 to 30%, and 2 to 5% respectively, 
respectively. While granulocytes derive mainly from the 
prostate and seminal vesicle, epididymis and rete testis 
primarily contribute to other types of white blood cells.84,88 
Comparing the seminal levels of leucocyte in fertile and 
infertile men, white blood cell numbers in fertile men are 
usually fewer. Nonetheless, the extremely wide overlapping 
leucocyte ranges in fertile and infertile men make it difficult to 
diagnose male infertility from seminal white blood cells.88 In its 
new Laboratory Manual for the Human Semen analysis, the 
World Health Organization has recommended89 a clinical cut-
off value of 1x106/mL of semen. On the other hand, a number of 
studies90,91 have questioned this value as being too high. Some 
authors indicated that an even greater number of leucocytes 
would not affect men's fertility92 or have beneficial effects on 
the induction of acrosome reactions.93 Barraud-Lange and co-
workers94 reported that Leukocyte concentrations below 1x106 
leukocytes/mL were associated with an increased fertilizer rate 
and outcomes of pregnancy. Nevertheless, recent research has 
not shown that high levels of leukocytes are detrimental to 
sperm functions, even if there is no clear limitation.95,96 
The association between asthenozoopsermia and azoospermia 
with male genital tract infections and inflammation suggest 
deleterious leukocytospermia effects on sperm function and 
integrity.97,98 In established assisted reproductive clinics, no 
negative consequences were observed of leucocytes on 
fertilization and pregnancy.99,100 Leukocytospermia may in fact 
have a different effect and outcome between patients. In 
bacterial infections, activated leukocytes were reported to cause 
more harm in patients with compromise of fertility101. Activated 
leukocytes invade infected organs and release high amounts of 
ROS that cause infertility through oxidative stress via 
membrane lipid peroxidation.75 Further studies are therefore 




During male reproductive tract inflammation, cytokines play 
both pleiotropic and redundant roles in mediating the immune 
responses. For example, the initial inflammatory responses are 
stimulated by the actions of IL6 and TNFα.38 Leukocytes are 
infiltrated in the seminal plasma and activated by IL6 and as the 
number of seminal leukocytes increases, they lead to toxicity 
via induction of higher generation of ROS causing oxidative 
stress. TNFα is responsible for induction of chemokine 
expression and germ cell apoptosis, thereby impairing 
spermatogenesis and sperm development.38,102,103 Neutrophil 
chemoattraction and infiltration into male reproductive tissues is 
also mediated by IL8.104 Activated neutrophils initiate the 
process of phagocytosis. Several other essential roles of 
cytokines on male fertility parameters are reported. These 
include, restructuring of blood–testis barrier by IL1,105 
association of IL2 and IL6 with dyspermia cases as it is found to 
negatively correlate with testosterone production by the Leydig 
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cells, while it may amplify the negative feedback of testosterone 
over luteinizing hormone production by the anterior 
pituitary;106,107 increase in IL4 in unexplained male infertility 
cases; negative correlation of IL17 and IL18 with sperm 
concentration and motility; association of IL21 with sperm auto-
antibodies production;107 and the role of interferons in 
unexplained male infertility cases.108 
LEUKOCYTES,	OXIDATIVE	STRESS	AND	MALE	FERTILITY 
Direct oxidation and disruption of plasma membrane lipids or 
DNA are the most noticeable results of OS. In addition, these 
functions may be over-stimulated leading to overreaction or 
early activation due to small amounts of ROS that lead to 
critical physiological events such as capacitation. 
Oxidative damage to membrane lipids 
In the absence of a cytoplasm with a relevant content of 
antioxidative defense enzymes, OS are particularly harmful to 
the sperm because the sperm plasma membrane contains an 
extraordinarily large amount of polyunsaturated fatty acids 
(PUFAs).37,109 Despite this dilemma, the antioxidant defense of 
seminal plasma usually involves high activity of superoxide 
dismutase (SOD) and catalase and has been shown to have a 
positive correlation between the development of these enzymes 
and the progressive sperm motility.110 In seminal plasma 
infertile patients with seminal total antioxidant capacity (TACs), 
which is a diagnostic criterion for male infertility, significantly 
lower SOD levels have been observed.111 
PUFA is lipids that are very likely to oxidize electrons 
throughout a broader area of the molecule with many conjugate 
carbon double-bonds in the molecule. When these PUFAs are 
attacked by ROS, they start LPOs by degrading the PUFAs by 
lipid peroxyl and lipids and forming eventually genotoxins (4-
hydroxy-2-alkenales, such as4-hydroxy-nonenales, resulting 
from ω6 fatty acids, such as DHA and 2-alkenales) as well as 
mutagens (Malondialdehyde).112,113 These by-products are, in 
effect, a major further danger for male germ cells because they 
harm DNA by producing DNA adduct (primarily pyrimido[1,2-
a]purine-10(3H)-one) that damage DNA indirectly114. Direct 
LPO damage to membrane lipids leads to a reduction in plasma 
and organelle membrane fluidity. Since sperm functions depend 
on membrane function, ion gradients and signal transduction 
mediated by receptors are compromised.115,116 Such processes 
eventually result in a loss of the functionality of the sperm cells, 
including fertilizing capacity.117 In this relation, it appears that 
the ROS generation site appears to play a role as leukocyte-
derived ROS, i.e. outside the cell, affects the plasma membrane 
and its functions, whereas sperm-derived ROS appears to affect 
the integrity of sperm nuclear DNA.23,118 Alternatively, sperm-
derived ROS could also target the mitochondrial membrane 
potential and mitochondrial DNA integrity directly.119,120 
Oxidative damage to DNA 
Oxidative stress also causes significant direct damage to 
nucleic (nDNA)121 and mitochondrial (mtDNA) DNA,120 in 
addition to damaging membrane lipids with indirect 
consequences for DNA and genome. The strong negative 
association between the fragmentation of nuclear DNA with 
male infertility indicators as standard sperm morphology and 
motility is especially significant. Since cells do not only contain 
the nuclear DNA, but also DNA (mtDNA) in the mitochondria, 
which is about 100-times more susceptible to assaults causing 
damage and mutations than nDNA because mtDNA is not 
protected by histones and protamines.122 Furthermore, mtDNA 
replicates more easily without proper proof reading and has 
only very simple repair systems for DNA55, rendering this 
DNA especially vulnerable for the OS.123 In this context, St. 
John et al.124 indicated a Potential risk of transmission of 
abnormal mtDNA for ART patients. More recently, Kao et al.125 
and Shamsi et al.126 reported that mtDNA and mtDNA 
mutations, ROS, are a major etiological cause for male 
infertility. Furthermore, Spiropoulos et al.127 showed that high 
levels of mtDNA mutations strongly correlate with poor sperm 
motility. Although mitochondrial DNA defects appear defective 
and inaccessible in oligoasthenozoospermic patients for 
amplification, mitochondria were functional for mobile 
sperm.128 Treulen and co-workers129 basically confirmed the 
idea that a potential breakdown of the mitochondrial membrane 
increases sperm ROS production, resulting in oxidative stress 
with reduced motility. Likewise, oxidative stress due to 
leukocytospermia will impair mitochondrial function by 
decreasing the capacity of the mitochondrial membrane, which 
would result in a vicious cycle with even more intracellular 
ROS output.13 
The discussion on the position of mtDNA continues with 
conflicting results from other studies. Lim et al.130 indicated that 
mtDNA would not undergo significant oxidative damage nor 
surpass that of nuclear DNA. Yet, in an analysis from a 
complete mtDNA sequencing of asthenozoospermic males, 
Pereira et al.131 showed no evidence of the role of mitochondrial 
involvement in germ cell selection in the sperm motility 
suggests the hypothesis132 would have to be treated very 
cautiously. Bandelt133 highlighted that the false mtDNA 
mutation association with male infertility would have been 
supported by misanalysis. 
CONCLUSION 
Male infertility is caused by many different 
inflammatory/infectious processes.134 It is therefore important, 
as each one has a unique damage mechanism and special 
susceptibility to antibiotics, to identifying the causative agent 
correctly when considering treatment. OS may serve as a 
common pathway by which several factors can cause male 
infertility. A modifiable lifestyle changes are recommended, 
such as cessations of tobacco / alcohol, healthy diet or 
antioxidant supplement with different chances of success. 
Antibiotic treatment remains the cornerstone of bacterial-
mediated infections, on the other hand, where certain antibiotics 
may cause oxidative damage too. Nonetheless, a rising 
possibility must be considered for infections with multidrug-
resistant bacterial strains. Although anti-retroviral therapy is 
used for the treatment of viral infection, nonnucleoside reverse 
transcriptase inhibitors are likely to reduce the fertility rate. To 
improve the efficacy of the treatment programs, further 
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significant steps need to be taken to understand the causes and 
consequences of infection mediated male fertility. 
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